BPC-157 + TB-500 ( Wolverine)

Wolverine 10/10mg — BPC-157 and TB-500 Regenerative Research Blend

Wolverine is a Phase One Labz dual-peptide research blend co-formulating 10mg BPC-157 with 10mg TB-500 in a single reconstitutable vial. The combination is the most-studied peptide pairing in tissue-regeneration research: the two compounds act through mechanistically distinct but biologically complementary pathways, and comparative studies have examined their combined effect against either peptide administered alone.

Mechanism of Action

BPC-157 modulates growth factor expression (VEGF, EGF, FGF), nitric oxide signaling, and the FAK–paxillin adhesion pathway, supporting angiogenesis, matrix organization, and cytoprotection. TB-500, the active fragment of Thymosin Beta-4, binds G-actin through its LKKTETQ motif and accelerates cell migration, reendothelialization, and cytoskeletal remodeling. Co-administration in preclinical studies has produced additive effects on capillary network density, migration speed, and matrix-closure kinetics — which is why the pairing has become a default research configuration for soft-tissue and tendon regeneration investigations.

Research Applications

• Tendon, ligament, and muscle regeneration combined-peptide studies
• Synergistic angiogenesis and capillary network research
• Cell migration and matrix remodeling investigations
• Dual-pathway recovery protocol modeling
• Cardiac and vascular tissue regeneration research
• Comparative studies vs single-peptide controls

Product Specifications

• Quantity: 10mg BPC-157 + 10mg TB-500 per vial
• Purity: ≥99% each component (HPLC verified)
• Form: Lyophilized powder (co-formulated)
• Storage: Refrigerate after reconstitution
• Testing: Third-party lab tested, COA available on Portal
• Actual Tested Value: 22.26 mg

For research purposes only. Not for human or veterinary use.